Novel Coronavirus Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Novel Coronavirus (COVID-19) Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Novel Coronavirus (COVID-19) Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Novel Coronavirus (COVID-19) Vaccine Overall Market Size
2.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size: 2022 VS 2028
2.2 Global Novel Coronavirus (COVID-19) Vaccine Market Size, Prospects & Forecasts: 2022-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Novel Coronavirus (COVID-19) Vaccine Players in Global Market
3.2 Global Companies Novel Coronavirus (COVID-19) Vaccine Product & Technology
4 Players Profiles
4.1 Inovio Pharmaceuticals
4.1.1 Inovio Pharmaceuticals Corporate Summary
4.1.2 Inovio Pharmaceuticals Business Overview
4.1.3 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.1.4 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.2 Takis Biotech (Evvivax)
4.2.1 Takis Biotech (Evvivax) Corporate Summary
4.2.2 Takis Biotech (Evvivax) Business Overview
4.2.3 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.2.4 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.3 Zydus Cadila
4.3.1 Zydus Cadila Corporate Summary
4.3.2 Zydus Cadila Business Overview
4.3.3 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.3.4 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.4 Codagenix, Inc.
4.4.1 Codagenix, Inc. Corporate Summary
4.4.2 Codagenix, Inc. Business Overview
4.4.3 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.4.4 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.5 GeoVax, Inc.
4.5.1 GeoVax, Inc. Corporate Summary
4.5.2 GeoVax, Inc. Business Overview
4.5.3 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.5.4 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.6 Bravovax
4.6.1 Bravovax Corporate Summary
4.6.2 Bravovax Business Overview
4.6.3 Bravovax Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.6.4 Bravovax Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.7 Janssen Pharmaceutical Companies
4.7.1 Janssen Pharmaceutical Companies Corporate Summary
4.7.2 Janssen Pharmaceutical Companies Business Overview
4.7.3 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.7.4 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.8 Altimmune
4.8.1 Altimmune Corporate Summary
4.8.2 Altimmune Business Overview
4.8.3 Altimmune Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.8.4 Altimmune Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.9 Vaxart
4.9.1 Vaxart Corporate Summary
4.9.2 Vaxart Business Overview
4.9.3 Vaxart Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.9.4 Vaxart Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.10 CanSino Biologics
4.10.1 CanSino Biologics Corporate Summary
4.10.2 CanSino Biologics Business Overview
4.10.3 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.10.4 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.11 ExpreS2ion Biotechnologies ApS
4.11.1 ExpreS2ion Biotechnologies ApS Corporate Summary
4.11.2 ExpreS2ion Biotechnologies ApS Business Overview
4.11.3 ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.11.4 ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.12 Clover Biopharmaceuticals
4.12.1 Clover Biopharmaceuticals Corporate Summary
4.12.2 Clover Biopharmaceuticals Business Overview
4.12.3 Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.12.4 Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.13 GSK
4.13.1 GSK Corporate Summary
4.13.2 GSK Business Overview
4.13.3 GSK Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.13.4 GSK Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.14 Vaxil Bio Ltd.
4.14.1 Vaxil Bio Ltd. Corporate Summary
4.14.2 Vaxil Bio Ltd. Business Overview
4.14.3 Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.14.4 Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.15 Generex
4.15.1 Generex Corporate Summary
4.15.2 Generex Business Overview
4.15.3 Generex Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.15.4 Generex Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.16 Novavax, Inc.
4.16.1 Novavax, Inc. Corporate Summary
4.16.2 Novavax, Inc. Business Overview
4.16.3 Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.16.4 Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.17 Sanofi Pasteur
4.17.1 Sanofi Pasteur Corporate Summary
4.17.2 Sanofi Pasteur Business Overview
4.17.3 Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.17.4 Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.18 Baylor
4.18.1 Baylor Corporate Summary
4.18.2 Baylor Business Overview
4.18.3 Baylor Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.18.4 Baylor Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.19 iBio, Inc.
4.19.1 iBio, Inc. Corporate Summary
4.19.2 iBio, Inc. Business Overview
4.19.3 iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.19.4 iBio, Inc. Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.20 Moderna, Inc.
4.20.1 Moderna, Inc. Corporate Summary
4.20.2 Moderna, Inc. Business Overview
4.20.3 Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.20.4 Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.21 Curevac
4.21.1 Curevac Corporate Summary
4.21.2 Curevac Business Overview
4.21.3 Curevac Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.21.4 Curevac Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
4.22 ImmunoPrecise
4.22.1 ImmunoPrecise Corporate Summary
4.22.2 ImmunoPrecise Business Overview
4.22.3 ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Product Offerings & Technology
4.22.4 ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine R&D, and Plans
5 Sights by Region
5.1 By Region - Global Novel Coronavirus (COVID-19) Vaccine Market Size, 2023 & 2028
5.2 By Region - Global Novel Coronavirus (COVID-19) Vaccine Revenue, (2023-2028)
5.3 United States
5.3.1 Key Players of Novel Coronavirus (COVID-19) Vaccine in United States
5.3.2 United States Novel Coronavirus (COVID-19) Vaccine Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Novel Coronavirus (COVID-19) Vaccine in Europe
5.4.2 Europe Novel Coronavirus (COVID-19) Vaccine Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Novel Coronavirus (COVID-19) Vaccine in China
5.5.2 China Novel Coronavirus (COVID-19) Vaccine Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 by Type - Global Novel Coronavirus (COVID-19) Vaccine Market Size Markets, 2023 & 2028
6.2 DNA
6.3 RNA
6.4 Others
7 Sights by Application
7.1 By Application - Global Novel Coronavirus (COVID-19) Vaccine Market Size, 2023 & 2028
7.2 Mild Symptom Patient
7.3 Critically Ill Patient
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Novel Coronavirus (COVID-19) Vaccine Market Opportunities & Trends in Global Market
Table 2. Novel Coronavirus (COVID-19) Vaccine Market Drivers in Global Market
Table 3. Novel Coronavirus (COVID-19) Vaccine Market Restraints in Global Market
Table 4. Key Players of Novel Coronavirus (COVID-19) Vaccine in Global Market
Table 5. Global Companies Novel Coronavirus (COVID-19) Vaccine Product & Technology
Table 6. Inovio Pharmaceuticals Corporate Summary
Table 7. Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 8. Takis Biotech (Evvivax) Corporate Summary
Table 9. Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 10. Zydus Cadila Corporate Summary
Table 11. Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 12. Codagenix, Inc. Corporate Summary
Table 13. Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 14. GeoVax, Inc. Corporate Summary
Table 15. GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 16. Bravovax Corporate Summary
Table 17. Bravovax Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 18. Janssen Pharmaceutical Companies Corporate Summary
Table 19. Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 20. Altimmune Corporate Summary
Table 21. Altimmune Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 22. Vaxart Corporate Summary
Table 23. Vaxart Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 24. CanSino Biologics Corporate Summary
Table 25. CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 26. ExpreS2ion Biotechnologies ApS Corporate Summary
Table 27. ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 28. Clover Biopharmaceuticals Corporate Summary
Table 29. Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 30. GSK Corporate Summary
Table 31. GSK Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 32. Vaxil Bio Ltd. Corporate Summary
Table 33. Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 34. Generex Corporate Summary
Table 35. Generex Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 36. Novavax, Inc. Corporate Summary
Table 37. Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 38. Sanofi Pasteur Corporate Summary
Table 39. Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 40. Baylor Corporate Summary
Table 41. Baylor Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 42. iBio, Inc. Corporate Summary
Table 43. iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 44. Moderna, Inc. Corporate Summary
Table 45. Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 46. Curevac Corporate Summary
Table 47. Curevac Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 48. ImmunoPrecise Corporate Summary
Table 49. ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Product Offerings
Table 50. By Region? Global Novel Coronavirus (COVID-19) Vaccine Revenue, (US$, Mn), 2023 & 2028
Table 51. By Region - Global Novel Coronavirus (COVID-19) Vaccine Revenue, (US$, Mn), 2023-2028
Table 52. By Type ? Global Novel Coronavirus (COVID-19) Vaccine Market Size, (US$, Mn), 2023 & 2028
Table 53. By Application? Global Novel Coronavirus (COVID-19) Vaccine Market Size, (US$, Mn), 2023 & 2028
List of Figures
Figure 1. Novel Coronavirus (COVID-19) Vaccine Segment by Type in 2021
Figure 2. Novel Coronavirus (COVID-19) Vaccine Segment by Application in 2021
Figure 3. Global Novel Coronavirus (COVID-19) Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Novel Coronavirus (COVID-19) Vaccine Market Size: 2022 VS 2028 (US$, Mn)
Figure 6. Global Novel Coronavirus (COVID-19) Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share, 2023-2028
Figure 8. By Type - Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share, 2023-2028
Figure 9. By Application - Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share, 2023-2028
Industry Market Size
